FMP

FMP

Enter

MRKR - Marker Therapeutics,...

photo-url-https://images.financialmodelingprep.com/symbol/MRKR.png

Marker Therapeutics, Inc.

MRKR

NASDAQ

Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufacture of non-engineered tumor-specific T cells that recognize multiple tumor-associated antigens and kill tumor cells expressing tumor-associated antigens. The company's MultiTAA-specific T cell therapies include autologous T cells for the treatment of lymphoma, and various solid tumors; allogeneic T cells for the treatment of acute myeloid leukemia and acute lymphoblastic leukemia; and off-the-shelf products in various indications. It is also developing TPIV100/110, a peptide-based immunotherapeutic vaccines for the treatment of breast and ovarian cancer cells; and TPIV200, which is in Phase 2 clinical trial for the treatment of breast and ovarian cancers. The company was founded in 1999 and is headquartered in Houston, Texas.

2.16 USD

-0.3 (-13.89%)

Free Cash Flow

Year

2019

2020

2021

2022

2023

2024

2025

2026

2027

2028

Revenue

2.83B

2.79B

2.91B

3.34B

2.71B

2.69B

2.68B

2.67B

2.66B

2.65B

Revenue %

-

-1.59

4.37

14.63

-18.94

-0.38

-0.38

-0.38

-0.38

Operating Cash Flow

697M

719M

629M

1.47B

885M

801.69M

798.64M

795.61M

792.59M

789.58M

Operating Cash Flow %

24.59

25.78

21.61

44.05

32.72

29.75

29.75

29.75

29.75

Cap Ex

-117M

-171M

-206M

-190M

-113M

-146.63M

-146.08M

-145.52M

-144.97M

-144.42M

Cap Ex %

-4.13

-6.13

-7.08

-5.69

-4.18

-5.44

-5.44

-5.44

-5.44

Free Cash Flow

580M

548M

423M

1.28B

772M

655.05M

652.56M

650.09M

647.62M

645.16M

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep